Tandem Diabetes Care Announces Third Quarter 2020 Financial Results and Updated Full Year 2020 Sales Guidance

Go back to Tandem Diabetes Care Announces Third Quarter 2020 Financial Results and Updated Full Year 2020 Sales Guidance

Tandem Diabetes (TNDM) Misses Q3 EPS by 5c, Revenues Beat; Offers FY20 Revenue Guidance Above Consensus

November 5, 2020 5:08 PM EST

Tandem Diabetes (NASDAQ: TNDM) reported Q3 EPS of ($0.15), $0.05 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $123.6 million versus the consensus estimate of $114.95 million.

Third Quarter 2020 Highlights

In comparing the third quarter of 2020 to the same period of 2019:

Worldwide pump... More